Pelvic lymphadenectomy during robot-assisted radical prostatectomy: Assessing nodal yield, perioperative outcomes, and complications. 2009

Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
Department of Surgery, University of Chicago Medical Center, Illinois 60637, USA. kevinzorn@hotmail.com

OBJECTIVE To describe our pelvic lymphadenectomy (PLND) technique during robot-assisted radical prostatectomy and to evaluate the nodal yield and perioperative outcomes. PLND is commonly performed with radical prostatectomy for localized prostate cancer. Because of the limitations of the robotic arm pitch in accessing the pelvic sidewall and undersurface of the iliac bifurcation, uro-oncologists have questioned the adequacy of robotic PLND. METHODS PLND was routinely performed on men with higher risk preoperative prostate cancer parameters (ie, prostrate-specific antigen >10 ng/mL, primary Gleason score > or =4, or clinical Stage T2b or greater). The outcomes of robot-assisted radical prostatectomy with bilateral, standard template PLND (group 1; n = 296 [26%]) were compared with those of a cohort of 859 robot-assisted radical prostatectomy patients (74%) without PLND (group 2). We also compared these data with those from a single-surgeon experience of open, standard-template PLND for retropubic radical prostatectomy. RESULTS The mean number of lymph nodes removed was 12.5 (interquartile range 7-16). The mean operative time (224 vs 216 minutes; P = .09), estimated blood loss (206 vs 229 mL; P = .14), and hospital stay (1.32 vs 1.24 days; P = .46) were comparable between the 2 groups. The rate of intraoperative complications (1% vs 1.5%; P = .2), overall postoperative complications (9% vs 7%; P = .8), and lymphocele formation (2% vs 0%; P = .9) were not significantly different. The review of our open series and the historically published open standard-template PLND series revealed a mean yield of 15 and a range of 6.7-15 lymph nodes removed, respectively. CONCLUSIONS Our data support the feasibility and low complication rate of robotic standard-template PLND with lymph node yields comparable to those with open PLND. Considering the low morbidity of PLND in experienced hands, coupled with the potential of preoperative undergrading and understaging and the therapeutic benefit to patients with micrometastatic disease, an increase in overall standard-template PLND use should be considered.

UI MeSH Term Description Entries
D007431 Intraoperative Complications Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure. Peroperative Complications,Surgical Injuries,Complication, Intraoperative,Complication, Peroperative,Injuries, Surgical,Complications, Intraoperative,Complications, Peroperative,Injury, Surgical,Intraoperative Complication,Peroperative Complication,Surgical Injury
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008210 Lymphocele Cystic mass containing lymph from diseased lymphatic channels or following surgical trauma or other injury. Cyst, Lymphatic,Lymphatic Cyst,Lymphocoele,Cysts, Lymphatic,Lymphatic Cysts,Lymphoceles,Lymphocoeles
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010388 Pelvis The space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM. Pelvic Region,Region, Pelvic
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011468 Prostatectomy Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE). Prostatectomy, Retropubic,Prostatectomy, Suprapubic,Prostatectomies,Prostatectomies, Retropubic,Prostatectomies, Suprapubic,Retropubic Prostatectomies,Retropubic Prostatectomy,Suprapubic Prostatectomies,Suprapubic Prostatectomy
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
August 2009, Urology,
Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
August 2009, Urology,
Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
June 1987, The Journal of urology,
Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
September 2012, European urology,
Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
November 2018, Molecular and clinical oncology,
Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
October 2008, Journal of endourology,
Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
January 2013, Urologia internationalis,
Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
April 2019, Archivos espanoles de urologia,
Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
September 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
Kevin C Zorn, and Mark H Katz, and Andrew Bernstein, and Sergey A Shikanov, and Charles B Brendler, and Gregory P Zagaja, and Arieh L Shalhav
June 2018, International journal of clinical oncology,
Copied contents to your clipboard!